Biomerica
BMRA | NASDAQ
$1.32
-$0.04 (-2.94%)
At close: Nov 16, 2026, 4:00 PM ET
$1.32
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-2.94%
(1D)No price chart data available for 1D timeframe.
Rating
20
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #992/1021 (Top 97%)
Key Statistics
Market Data
Market Cap $6.07M
1D Range
1.32 1.37
52W Range
1.30 2.88
Valuation (TTM)
PE -0.81
PB 1.66
EV/EBITDA -1.12
Valuation (NTM)
Forward PE N/A
Forward PEG 0.14
Price Target $0.00
Cash Flow
FCF Yield -65.8%
SBC Adj. FCF Yield -73.6%
SBC Impact -11.9%
Margins
Gross Margin 0.9%
Operating Margin -125.2%
FCF Margin -92.0%
Growth (CAGR)
Revenue 3Y | 5Y -7.1% |
-9.9%
Dil EPS 3Y | 5Y -83.9% |
-37.5%
FCF 3Y | 5Y 13.8% |
-1.4%
Returns
ROA -62.1%
ROE -142.8%
ROIC -90.9%
Financial Health
Net Cash
$2.23M
Current Ratio 1.91
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Biomerica, Inc. is a biomedical technology firm that invents, secures intellectual property for, produces, and globally distributes diagnostic and therapeutic solutions aimed at identifying and addres...
Sector Healthcare
Industry Medical - Devices
Employees 50
IPO Date Sep 7, 1984
Website www.biomerica.com
Fiscal Year June - May
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove BMRA